Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 97, Issue 7

April 1 2001

In this Issue

INSIDE BLOOD
PLENARY PAPERS
HOW I TREAT
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
RED CELLS
BRIEF REPORTS
CORRESPONDENCE

INSIDE BLOOD

Plasma glycolipids levels: new factors regulating the protein C anticoagulant pathway and determining thrombotic risk

Charles T. Esmon

View Articletitled, Plasma glycolipids levels: new factors regulating the protein C anticoagulant pathway and determining thrombotic risk

Fractalkine and atherosclerosis: a new role for a curious chemokine

Israel F. Charo

View Articletitled, Fractalkine and atherosclerosis: a new role for a curious chemokine

Defective DNA repair in CML

Bruno Calabretta

View Articletitled, Defective DNA repair in CML

Understanding cellular networks in the year 2001

Stephen Nimer

View Articletitled, Understanding cellular networks in the year 2001

PLENARY PAPERS

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway
Clinical Trials & Observations

Hiroshi Deguchi,JoséA. Fernández,Ingrid Pabinger,John A. Heit,John H. Griffin

View Articletitled, Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway

HOW I TREAT

How I treat patients with von Willebrand disease
Clinical Trials & Observations

Pier Mannuccio Mannucci

View Articletitled, How I treat patients with von Willebrand disease

CHEMOKINES

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

Patricia Ogilvie,Giuseppe Bardi,Ian Clark-Lewis,Marco Baggiolini,Mariagrazia Uguccioni

View Articletitled, Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

Didier Moatti,Sophie Faure,Frédéric Fumeron,Mohamed El Walid Amara,Patrick Seknadji,David H. McDermott,Patrice Debré,Marie Claude Aumont,Philip M. Murphy,Dominique de Prost,Christophe Combadière

View Articletitled, Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS

Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol
Clinical Trials & Observations

Ariela Noy,Ravi Verma,Martha Glenn,Peter Maslak,Zia U. Rahman,James R. Keenan,Mark Weiss,Daniel Filippa,Andrew D. Zelenetz

View Articletitled, Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol

Modulation of endothelial cell activation in sickle cell disease: a pilot study
Clinical Trials & Observations

Alex A. Solovey,Anna N. Solovey,Jeanne Harkness,Robert P. Hebbel

View Articletitled, Modulation of endothelial cell activation in sickle cell disease: a pilot study

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
Clinical Trials & Observations

John E. Janik,Langdon L. Miller,Edward L. Korn,Diane Stevens,Brendan D. Curti,John W. Smith, II,Mario Sznol,Kevin C. Conlon,William Sharfman,Walter J. Urba,Barry L. Gause,Dan L. Longo

View Articletitled, A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome
Clinical Trials & Observations

Corrina McMahon,Andrew Will,Peiyi Hu,Gul N. Shah,William S. Sly,Owen P. Smith

View Articletitled, Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome

GENE THERAPY

Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34⁺ hematopoietic cells

Michael Rosenzweig,Michelle Connole,Rhona Glickman,Soon-Pak Shinji Yue,Bradley Noren,MaryAnn DeMaria,R. Paul Johnson

View Articletitled, Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells

HEMATOPOIESIS

Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells

Francis N. Karanu,Barbara Murdoch,Tomoyuki Miyabayashi,Mitsuhara Ohno,Masahide Koremoto,Lisa Gallacher,Dongmei Wu,Akira Itoh,Seiji Sakano,Mickie Bhatia

View Articletitled, Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells

Erythroblasts are a source of angiogenic factors

Rafaèle Tordjman,Stéphanie Delaire,Jean Plouët,Stephen Ting,Philippe Gaulard,Serge Fichelson,Paul-Henri Roméo,Valérie Lemarchandel

View Articletitled, Erythroblasts are a source of angiogenic factors

Cross-talk between α₄β₁/α₅β₁ and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways

Reuben Kapur,Ryan Cooper,Lei Zhang,David A. Williams

View Articletitled, Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways

CD9 and megakaryocyte differentiation

Denis Clay,Eric Rubinstein,Zohair Mishal,Aurora Anjo,Michel Prenant,Claude Jasmin,Claude Boucheix,Marie-Caroline Le Bousse-Kerdilès

View Articletitled, CD9 and megakaryocyte differentiation

Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF β-receptor null mice

Wolfgang E. Kaminski,Per Lindahl,Nancy L. Lin,Virginia C. Broudy,Jeffrey R. Crosby,Mats Hellström,Birgitta Swolin,Daniel F. Bowen-Pope,Paul J. Martin,Russell Ross,Christer Betsholtz,Elaine W. Raines

View Articletitled, Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF β-receptor null mice

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Yasuhiko Kano,Miyuki Akutsu,Saburo Tsunoda,Hiroyuki Mano,Yuko Sato,Yoshio Honma,Yusuke Furukawa

View Articletitled, In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL–expressing cells, demonstrating synergy between AG490 and STI571
Clinical Trials & Observations

Xuemei Sun,Judith E. Layton,Andrew Elefanty,Graham J. Lieschke

View Articletitled, Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL–expressing cells, demonstrating synergy between AG490 and STI571

Evidence for the presence of murine primitive megakarycytopoiesis in the early yolk sac

Ming-jiang Xu,Sahoko Matsuoka,Feng-Chun Yang,Yasuhiro Ebihara,Atsushi Manabe,Ryuhei Tanaka,Mitsuoki Eguchi,Shigetaka Asano,Tatsutoshi Nakahata,Kohichiro Tsuji

View Articletitled, Evidence for the presence of murine primitive megakarycytopoiesis in the early yolk sac

Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates

Najet Debili,Catherine Robin,Valérie Schiavon,Rémi Letestu,Françoise Pflumio,Maria-Teresa Mitjavila-Garcia,Laure Coulombel,William Vainchenker

View Articletitled, Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates

Signal transduction pathways involved in soluble fractalkine–induced monocytic cell adhesion

Bèatrice Cambien,Manuel Pomeranz,Heidy Schmid-Antomarchi,Marie-Ange Millet,Violette Breittmayer,Bernard Rossi,Annie Schmid-Alliana

View Articletitled, Signal transduction pathways involved in soluble fractalkine–induced monocytic cell adhesion

Importance of leucine zipper domain of mitranscription factor (MITF) for differentiation of mast cells demonstrated using mi^ce/mi^ce mutant mice of which MITF lacks the zipper domain

Eiichi Morii,Hideki Ogihara,Dae-Ki Kim,Akihiko Ito,Keisuke Oboki,Young-Mi Lee,Tomoko Jippo,Shintaro Nomura,Kazutaka Maeyama,M. Lynn Lamoreux,Yukihiko Kitamura

View Articletitled, Importance of leucine zipper domain of mitranscription factor (MITF) for differentiation of mast cells demonstrated using mice/mice mutant mice of which MITF lacks the zipper domain

Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes

Naotomo Kambe,Michiyo Kambe,Jarema P. Kochan,Lawrence B. Schwartz

View Articletitled, Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

Mireille Henry,Hélène Aubert,Pierre E. Morange,Isabelle Nanni,Marie-Christine Alessi,Laurence Tiret,Irène Juhan-Vague

View Articletitled, Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

Reinhard Schneppenheim,Ulrich Budde,Tobias Obser,Jacqueline Brassard,Kerstin Mainusch,Zaverio M. Ruggeri,Sonja Schneppenheim,Rainer Schwaab,Johannes Oldenburg

View Articletitled, Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

IMMUNOBIOLOGY

TRAIL expression by activated human CD4⁺Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

Mie Nieda,Andrew Nicol,Yashuhiko Koezuka,Akiko Kikuchi,Natalia Lapteva,Yuji Tanaka,Katsushi Tokunaga,Kenji Suzuki,Nobuhiko Kayagaki,Hideo Yagita,Hisamaru Hirai,Takeo Juji

View Articletitled, TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice

Akihiko Ito,Tatsuki R. Kataoka,Dae-Ki Kim,Yu-ichiro Koma,Young-Mi Lee,Yukihiko Kitamura

View Articletitled, Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice

NEOPLASIA

BCR-ABL down-regulates the DNA repair protein DNA-PKcs

Eric Deutsch,Aymeric Dugray,Bassam AbdulKarim,Elisabetta Marangoni,Laurence Maggiorella,Sabine Vaganay,Radia M'Kacher,Setha Douc Rasy,François Eschwege,William Vainchenker,Ali G. Turhan,Jean Bourhis

View Articletitled, BCR-ABL down-regulates the DNA repair protein DNA-PKcs

Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function

Carsten Müller-Tidow,Wenbing Wang,Gregory E. Idos,Sven Diederichs,Rong Yang,Carol Readhead,Wolfgang E. Berdel,Hubert Serve,Mark Saville,Roger Watson,H. Phillip Koeffler

View Articletitled, Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

Anna Migliazza,Francesc Bosch,Hirokazu Komatsu,Eftihia Cayanis,Stefano Martinotti,Elena Toniato,Ernesto Guccione,Xiaoyan Qu,Minchen Chien,V. V. V. Murty,Gianluca Gaidano,Giorgio Inghirami,Peisen Zhang,Stuart Fischer,Sergey M. Kalachikov,James Russo,Isidore Edelman,Argiris Efstratiadis,Riccardo Dalla-Favera

View Articletitled, Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade

Julie A. Vrana,Steven Grant

View Articletitled, Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade

Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia

Jiann-Shiuh Chen,Elaine Coustan-Smith,Toshio Suzuki,Geoffrey A. Neale,Keichiro Mihara,Ching-Hon Pui,Dario Campana

View Articletitled, Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia

Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination

Anne Stucki,Anne-Sophie Rivier,Milica Gikic,Natacha Monai,Marc Schapira,Olivier Spertini

View Articletitled, Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination

Kaposi sarcoma–associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders

Ming-Qing Du,Hongxiang Liu,Tim C. Diss,Hongtao Ye,Rifat A. Hamoudi,Nicolas Dupin,Véronique Meignin,Eric Oksenhendler,Chris Boshoff,Peter G. Isaacson

View Articletitled, Kaposi sarcoma–associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders

Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300

Naoki Mori,Mariko Morishita,Tomoo Tsukazaki,Chou-Zen Giam,Atsushi Kumatori,Yuetsu Tanaka,Naoki Yamamoto

View Articletitled, Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300

RED CELLS

Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease

Hanna Gazda,Jeffrey M. Lipton,Thiébaut-Noël Willig,Sarah Ball,Charlotte M. Niemeyer,Gil Tchernia,Narla Mohandas,Mark J. Daly,Anna Ploszynska,Karen A. Orfali,Adrianna Vlachos,Bertil E. Glader,Roma Rokicka-Milewska,Akira Ohara,David Baker,Dagmar Pospisilova,Allison Webber,David H. Viskochil,David G. Nathan,Alan H. Beggs,Colin A. Sieff

View Articletitled, Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease

Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice

Jefferson Y. Chan,Mandy Kwong,Margaret Lo,Renee Emerson,Frans A. Kuypers

View Articletitled, Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice

Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin

Julia E. Brittain,Kathryn J. Mlinar,Christopher S. Anderson,Eugene P. Orringer,Leslie V. Parise

View Articletitled, Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin

BRIEF REPORTS

Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery
Clinical Trials & Observations Brief Report

Markus Schmugge,Hannes Frischknecht,Yasuhiro Yonekawa,Ralf W. Baumgartner,Eugen Boltshauser,James Humbert

View Articletitled, Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery

Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein
Brief Report

Robert Hromas,Tracey Busse,Audra Carroll,David Mack,Rinah Shopnick,Dong-Er Zhang,Harikrishna Nakshatri,Kathleen Richkind

View Articletitled, Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein

Autoantibodies to α_IIbβ₃ in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on α_IIb
Brief Report

Robert McMillan,Jennifer Lopez-Dee,Joseph C. Loftus

View Articletitled, Autoantibodies to αIIbβ3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on αIIb

Detection of viral interleukin-6 in Kaposi sarcoma–associated herpesvirus–linked disorders
Brief Report

Yoshiyasu Aoki,Robert Yarchoan,Kathleen Wyvill,Shin-ichiro Okamoto,Richard F. Little,Giovanna Tosato

View Articletitled, Detection of viral interleukin-6 in Kaposi sarcoma–associated herpesvirus–linked disorders

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells
Brief Report

Monica L. Guzman,Donna Upchurch,Barry Grimes,Dianna S. Howard,David A. Rizzieri,Selina M. Luger,Gordon L. Phillips,Craig T. Jordan

View Articletitled, Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells

CORRESPONDENCE

Splenectomy and hemopoietic stem cell transplantation for myelofibrosis

Zihai Li,Ted Gooley,Frederick R. Appelbaum,H. Joachim Deeg

View Articletitled, Splenectomy and hemopoietic stem cell transplantation for myelofibrosis

Flow cytometry cannot assess surface binding of perforin to target cells

Sunil S. Metkar,M. Aguilar-Santelises,Baikun Wang,Christopher J. Froelich

View Articletitled, Flow cytometry cannot assess surface binding of perforin to target cells

Risk for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

Holger Hebart,Wolfram Brugger,Ulrich Grigoleit,Barbara Gscheidle,Juergen Loeffler,Hansjörg Schäfer,Lothar Kanz,Hermann Einsele,Christian Sinzger

View Articletitled, Risk for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

Significance of neutrophil elastase mutations versus G-CSF receptor mutations for leukemic progression of congenital neutropenia

Mirjam H. A. Hermans,Ivo P. Touw

View Articletitled, Significance of neutrophil elastase mutations versus G-CSF receptor mutations for leukemic progression of congenital neutropenia

Drug-dependent antibodies against the prodrug carbimazole do not react with the active metabolite thiamazole

Hartmut Kroll,Astrid Giptner,Sentot Santoso

View Articletitled, Drug-dependent antibodies against the prodrug carbimazole do not react with the active metabolite thiamazole

BCR-ABL rearrangement is not detectable in essential thrombocythemia

Giovanni Emilia,Roberto Marasca,Patrizia Zucchini,Paola Temperani,Mario Luppi,Giuseppe Torelli,Francesco Lanza,Cristiano De Angelis,Domenica Gandini,GianLuigi Castoldi,Daniele Vallisa,Luigi Cavanna,Laura del Senno

View Articletitled, BCR-ABL rearrangement is not detectable in essential thrombocythemia

Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndrome

Carl-Erik Dempfle,Christine Burck,Tina Grützmacher,Jan Wizenmann,Dieter L. Heene

View Articletitled, Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndrome

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia

Structure-based design of therapeutics to control hemostasis

How I treat chronic myeloid leukemia in children and adolescents

Metabolic Pathways in Deep Vein Thrombosis: A New Frontier for Therapeutic Intervention

Advertisement intended for health care professionals

Issue Archive

Table of Contents

INSIDE BLOOD

PLENARY PAPERS

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway Clinical Trials & Observations

HOW I TREAT

How I treat patients with von Willebrand disease Clinical Trials & Observations

CHEMOKINES

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS

Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol Clinical Trials & Observations

Modulation of endothelial cell activation in sickle cell disease: a pilot study Clinical Trials & Observations

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma Clinical Trials & Observations

Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome Clinical Trials & Observations

GENE THERAPY

HEMATOPOIESIS

Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL–expressing cells, demonstrating synergy between AG490 and STI571 Clinical Trials & Observations

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

IMMUNOBIOLOGY

NEOPLASIA

RED CELLS

BRIEF REPORTS

Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery Clinical Trials & Observations Brief Report

Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein Brief Report

Autoantibodies to αIIbβ3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on αIIb Brief Report

Detection of viral interleukin-6 in Kaposi sarcoma–associated herpesvirus–linked disorders Brief Report

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells Brief Report